FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

407894001: Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2151724011 Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2159478014 Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2151724011 Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2159478014 Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL Is a Product containing insulin aspart and insulin aspart protamine (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Pancreatic hormone false Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Human insulin (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. insulina aspartat false Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Short-acting insulin false Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL Has manufactured dose form Injection (product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Biphasic insulin false Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Insulin aspart protamine false Inferred relationship Existential restriction modifier (core metadata concept)
    Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL Is a Product manufactured as parenteral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    Back to Start